Page last updated: 2024-08-24

capecitabine and Adenocarcinoma, Scirrhous

capecitabine has been researched along with Adenocarcinoma, Scirrhous in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasegawa, N; Iimura, Y; Kaneko, H; Kawabata, M; Konishi, K; Shoji, Y	1
Aono, T; Iwase, K; Nakamura, Y; Nomura, M; Tanaka, Y	1
Hamamoto, Y; Nishi, T; Onodera, K; Uemoto, J; Warita, E; Yamanaka, Y	1
Ishiba, T; Kasahara, M; Nagahara, M; Nakagawa, T; Sato, T; Sugihara, K; Sugimoto, H; Tamura, N; Yamauchi, S	1
Akimoto, T; Hasegawa, K; Kishimoto, Y; Morimoto, Y; Sawai, T	1

Reviews

1 review(s) available for capecitabine and Adenocarcinoma, Scirrhous

Article	Year
[A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12 Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Hydronephrosis; Middle Aged; Peritoneal Neoplasms	2012

Other Studies

4 other study(ies) available for capecitabine and Adenocarcinoma, Scirrhous

Article	Year
[A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9 Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Skin Ulcer	2009
[Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11 Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Female; Fluorouracil; Humans; Lapatinib; Lung Neoplasms; Lymph Node Excision; Mastectomy; Middle Aged; Quinazolines; Receptor, ErbB-2	2010
[A complete response of scirrhous gastric carcinoma treated with trastuzumab combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:13 Topics: Adenocarcinoma, Scirrhous; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Fatal Outcome; Fluorouracil; Humans; Male; Middle Aged; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab	2012
[Significance of tissue thymidine phosphorylase and dihydropyrimidine dehydrogenase activities in ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:13 Topics: 5'-Nucleotidase; Adenocarcinoma, Scirrhous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Survival Rate	2004